Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.
Kim N ChiDana RathkopfMatthew R SmithEleni EfstathiouGerhardt AttardDavid OlmosJi Youl LeeEric J SmallAndrea Juliana Pereira de Santana GomesGuilhem RoubaudMarniza SaadBogdan ZurawskiValerii SakaloGary E MasonPeter FrancisGeorge WangDaphne WuBrooke DiorioAngela Lopez-GitlitzShahneen Sandhunull nullPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Combination treatment with niraparib + AAP significantly lengthened rPFS in patients with HRR+ mCRPC compared with standard-of-care AAP.